PYVSX
Price
$16.51
Change
+$0.17 (+1.04%)
Updated
Dec 24 closing price
RMEBX
Price
$55.73
Change
+$0.45 (+0.81%)
Updated
Dec 24 closing price
Ad is loading...

PYVSX vs RMEBX

Header iconPYVSX vs RMEBX Comparison
Open Charts PYVSX vs RMEBXBanner chart's image
Payden Equity Income SI
Price$16.51
Change+$0.17 (+1.04%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$55.73
Change+$0.45 (+0.81%)
VolumeN/A
CapitalizationN/A
PYVSX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PYVSX vs. RMEBX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYVSX is a StrongBuy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 103B vs. PYVSX (1.02B). PYVSX (1.57) and RMEBX (1.54) have matching dividends . PYVSX was incepted earlier than RMEBX: PYVSX (10 years) vs RMEBX (10 years). PYVSX is a more actively managed with annual turnover of: 111.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than PYVSX: RMEBX (250) vs PYVSX (10000000). RMEBX annual gain was more profitable for investors over the last year : 11.90 vs. PYVSX (1.82). RMEBX return over 5 years is better than : 38.18 vs. PYVSX (0.07).
PYVSXRMEBXPYVSX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD1.35811.15312%
Front LoadN/AN/A-
Min. Initial Investment100000002504,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B103B1%
Annual Yield % from dividends1.571.54102%
Returns for 1 year1.8211.9015%
Returns for 3 years-4.1511.77-35%
Returns for 5 years0.0738.180%
Returns for 10 years46.5458.9979%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRNS0.260.02
+8.07%
Marinus Pharmaceuticals
EXPD111.190.69
+0.62%
Expeditors International of Washington
PRTA15.400.07
+0.46%
Prothena Corp
FATE1.66N/A
N/A
Fate Therapeutics
RNG36.99-0.36
-0.96%
RINGCENTRAL